🇺🇸 FDA
Patent

US 8513279

Quinuclidine derivatives and medicinal compositions containing the same

granted A61KA61K31/439A61K31/4745

Quick answer

US patent 8513279 (Quinuclidine derivatives and medicinal compositions containing the same) held by Almirall, S.A. expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/439, A61K31/4745, A61K31/56, A61K45/06